SEC Filing Details

Document Details

Filing Date
Jan 30, 2008
Document Date
Jan 30, 2008
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
3,4,5
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.
Filer
BIOTECHNOLOGY VALUE FUND L P

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline